Terms: = Liver cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Staging
7 results:
1. Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
Nicolosi A; Gaia S; Risso A; Rosso C; Rolle E; Abate ML; Olivero A; Armandi A; Ribaldone DG; Carucci P; Fagoonee S; Pellicano R; Saracco GM; Bugianesi E; Caviglia GP
Minerva Gastroenterol (Torino); 2022 Dec; 68(4):378-386. PubMed ID: 36222678
[TBL] [Abstract] [Full Text] [Related]
2. GENES EXPRESSION AND SERUM BIOMARKERS FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA, CIRRHOSIS AND HEPATITIS C.
Fernandes-Ferreira R; Tenani GD; Pinhel MAS; Abrantes AMC; Botelho MFRR; Silva RCMAD; Souza DRS; Silva RFD
Arq Gastroenterol; 2022; 59(3):394-401. PubMed ID: 36102438
[TBL] [Abstract] [Full Text] [Related]
3. The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression.
Xue R; Feng J; Meng Q; Lv F; Zhu Y; Yu H; Zhang S; Song C; Sun L; Yue Z; Feng S; Che R; Xiang Q; Jing X
J Gastroenterol Hepatol; 2017 Aug; 32(8):1503-1511. PubMed ID: 28087980
[TBL] [Abstract] [Full Text] [Related]
4. Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma.
Wang L; Pan L; Yao M; Cai Y; Dong Z; Yao D
Oncotarget; 2016 Jul; 7(27):42150-42158. PubMed ID: 27286460
[TBL] [Abstract] [Full Text] [Related]
5. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
[TBL] [Abstract] [Full Text] [Related]
6. Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles.
Park JO; Stephen Z; Sun C; Veiseh O; Kievit FM; Fang C; Leung M; Mok H; Zhang M
Mol Imaging; 2011 Feb; 10(1):69-77. PubMed ID: 21303616
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma.
Liu H; Li P; Zhai Y; Qu CF; Zhang LJ; Tan YF; Li N; Ding HG
World J Gastroenterol; 2010 Sep; 16(35):4410-5. PubMed ID: 20845507
[TBL] [Abstract] [Full Text] [Related]
